Bactiguard Holding AB
STO:BACTI B

Watchlist Manager
Bactiguard Holding AB Logo
Bactiguard Holding AB
STO:BACTI B
Watchlist
Price: 16.55 SEK 11.45% Market Closed
Market Cap: kr513.7m

Relative Value

The Relative Value of one BACTI B stock under the Base Case scenario is 24.9 SEK. Compared to the current market price of 16.55 SEK, Bactiguard Holding AB is Undervalued by 34%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BACTI B Relative Value
Base Case
24.9 SEK
Undervaluation 34%
Relative Value
Price
Worst Case
Base Case
Best Case

Multiples Across Competitors

BACTI B Competitors Multiples
Bactiguard Holding AB Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SE
Bactiguard Holding AB
STO:BACTI B
513.7m SEK 2.2 -23.4 -32.2 -32.2
US
Medline Inc
NASDAQ:MDLN
60B USD 0 0 0 0
JP
Hoya Corp
TSE:7741
8.9T JPY 9.8 35.7 25.7 30.9
CH
Alcon AG
SIX:ALC
29.6B CHF 3.8 37.3 15.4 30
DK
Coloplast A/S
CSE:COLO B
109.6B DKK 4 30.9 14.4 17.1
US
Align Technology Inc
NASDAQ:ALGN
13.5B USD 3.4 35.5 16.1 20.5
UK
ConvaTec Group PLC
LSE:CTEC
4.6B GBP 2.7 29.2 13 21.1
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
42.8B CNY 9.4 26 23.5 23.5
CA
Bausch + Lomb Corp
NYSE:BLCO
6B USD 1.2 -19.7 19.6 92.4
CH
Ypsomed Holding AG
SIX:YPSN
3.9B CHF 5 20.4 13.2 18
US
Merit Medical Systems Inc
NASDAQ:MMSI
4.8B USD 3.2 40.4 18.4 30.7
P/E Multiple
Earnings Growth PEG
SE
Bactiguard Holding AB
STO:BACTI B
Average P/E: 31.9
Negative Multiple: -23.4
N/A N/A
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
JP
Hoya Corp
TSE:7741
35.7
13%
2.7
CH
Alcon AG
SIX:ALC
37.3
25%
1.5
DK
Coloplast A/S
CSE:COLO B
30.9
22%
1.4
US
Align Technology Inc
NASDAQ:ALGN
35.5
27%
1.3
UK
ConvaTec Group PLC
LSE:CTEC
29.2
33%
0.9
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
26
9%
2.9
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -19.7 N/A N/A
CH
Ypsomed Holding AG
SIX:YPSN
20.4
32%
0.6
US
Merit Medical Systems Inc
NASDAQ:MMSI
40.4
30%
1.3
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
SE
Bactiguard Holding AB
STO:BACTI B
Average EV/EBITDA: 17.7
Negative Multiple: -32.2
30%
N/A
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
JP
Hoya Corp
TSE:7741
25.7
11%
2.3
CH
Alcon AG
SIX:ALC
15.4
8%
1.9
DK
Coloplast A/S
CSE:COLO B
14.4
8%
1.8
US
Align Technology Inc
NASDAQ:ALGN
16.1
13%
1.2
UK
ConvaTec Group PLC
LSE:CTEC
13
10%
1.3
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
23.5
15%
1.6
CA
Bausch + Lomb Corp
NYSE:BLCO
19.6
21%
0.9
CH
Ypsomed Holding AG
SIX:YPSN
13.2
21%
0.6
US
Merit Medical Systems Inc
NASDAQ:MMSI
18.4
16%
1.2
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
SE
Bactiguard Holding AB
STO:BACTI B
Average EV/EBIT: 31.6
Negative Multiple: -32.2
N/A N/A
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
JP
Hoya Corp
TSE:7741
30.9
N/A N/A
CH
Alcon AG
SIX:ALC
30
23%
1.3
DK
Coloplast A/S
CSE:COLO B
17.1
8%
2.1
US
Align Technology Inc
NASDAQ:ALGN
20.5
16%
1.3
UK
ConvaTec Group PLC
LSE:CTEC
21.1
22%
1
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
23.5
11%
2.1
CA
Bausch + Lomb Corp
NYSE:BLCO
92.4
60%
1.5
CH
Ypsomed Holding AG
SIX:YPSN
18
29%
0.6
US
Merit Medical Systems Inc
NASDAQ:MMSI
30.7
30%
1